High-throughput proteomics uncovers exercise training and type 2 diabetes–induced changes in human white adipose tissue
Science Advances · 2023-12 · 9 (48)
DOI: 10.1126/sciadv.adi7548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023-12. Verfasst von Jeppe Kjærgaard Larsen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Novo Nordisk Foundation (NNF) to NNF Center for Basic Metabolic Research, EFSD/Novo Nordisk Foundation Future Leaders Awards Program to A.S.D., Region of Southern Denmark, Odense University Hospital, the Novo Nordisk Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
White adipose tissue (WAT) is important for metabolic homeostasis. We established the differential proteomic signatures of WAT in glucose-tolerant lean and obese individuals and patients with type 2 diabetes (T2D) and the response to 8 weeks of high-intensity interval training (HIIT). Using a high-throughput and reproducible mass spectrometry–based proteomics pipeline, we identified 3773 proteins and found that most regulated proteins displayed progression in markers of dysfunctional WAT from lean to obese to T2D individuals and were highly associated with clinical measures such as insulin sensitivity and HbA1c. We propose that these distinct markers could serve as potential clinical biomarkers. HIIT induced only minor changes in the WAT proteome. This included an increase in WAT ferritin levels independent of obesity and T2D, and WAT ferritin levels were strongly correlated with individual insulin sensitivity. Together, we report a proteomic signature of WAT related to obesity and T2D and highlight an unrecognized role of human WAT iron metabolism in exercise training adaptations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
- Steno Diabetes Center Odense, Odense University Hospital, Odense C, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.
- Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Jeppe Kjærgaard Larsen, Rikke Kruse, Navid Sahebekhtiari, Maria H Petersen, Martin E de Almeida, Niels Ørtenblad, Atul S Deshmukh, Kurt Højlund
Förderung
- Novo Nordisk Foundation (NNF) to NNF Center for Basic Metabolic Research
- EFSD/Novo Nordisk Foundation Future Leaders Awards Program to A.S.D.
- Region of Southern Denmark, Odense University Hospital, the Novo Nordisk Foundation
- University of Southern Denmark, Region of Southern Denmark
Zitieren
APA
Larsen, J. K., Kruse, R., Sahebekhtiari, N., Moreno-Justicia, R., Gomez Jorba, G., Petersen, M. H., de Almeida, M. E., Ørtenblad, N., Deshmukh, A. S., & Højlund, K. (2023). High-throughput proteomics uncovers exercise training and type 2 diabetes–induced changes in human white adipose tissue. Science Advances, 9(48). https://doi.org/10.1126/sciadv.adi7548
Vancouver
Larsen JK, Kruse R, Sahebekhtiari N, Moreno-Justicia R, Gomez Jorba G, Petersen MH, et al. High-throughput proteomics uncovers exercise training and type 2 diabetes–induced changes in human white adipose tissue. Science Advances. 2023;9(48). doi:10.1126/sciadv.adi7548
BibTeX
@article{Larsen2023,
author = {Larsen, Jeppe Kjærgaard and Kruse, Rikke and Sahebekhtiari, Navid and Moreno-Justicia, Roger and Gomez Jorba, Gerard and Petersen, Maria H and de Almeida, Martin E and Ørtenblad, Niels and Deshmukh, Atul S and Højlund, Kurt},
title = {High-throughput proteomics uncovers exercise training and type 2 diabetes–induced changes in human white adipose tissue},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {48},
doi = {10.1126/sciadv.adi7548}
}
EUVIMED